Cytokines in cancer immunotherapy
TA Waldmann - Cold Spring Harbor perspectives in …, 2018 - cshperspectives.cshlp.org
Cytokines that control the immune response were shown to have efficacy in preclinical
murine cancer models. Interferon (IFN)-α is approved for treatment of hairy cell leukemia …
murine cancer models. Interferon (IFN)-α is approved for treatment of hairy cell leukemia …
Cytokines in clinical cancer immunotherapy
P Berraondo, MF Sanmamed, MC Ochoa… - British journal of …, 2019 - nature.com
Cytokines are soluble proteins that mediate cell-to-cell communication. Based on the
discovery of the potent anti-tumour activities of several pro-inflammatory cytokines in animal …
discovery of the potent anti-tumour activities of several pro-inflammatory cytokines in animal …
[HTML][HTML] Mechanism of action of immunotherapy
ML Disis - Seminars in oncology, 2014 - Elsevier
The immune system plays a vital role in regulating the growth of tumors. Some types of
inflammatory responses can promote tumor growth, while a tumor-specific adaptive immune …
inflammatory responses can promote tumor growth, while a tumor-specific adaptive immune …
Cytokines in the treatment of cancer
KC Conlon, MD Miljkovic… - Journal of Interferon & …, 2019 - liebertpub.com
Cytokines are major regulators of innate and adaptive immunity that enable cells of the
immune system to communicate over short distances. Cytokine therapy to activate the …
immune system to communicate over short distances. Cytokine therapy to activate the …
Frontiers in cancer immunotherapy—a symposium report
J Cable, B Greenbaum, D Pe'er… - Annals of the New …, 2021 - Wiley Online Library
Cancer immunotherapy has dramatically changed the approach to cancer treatment. The
aim of targeting the immune system to recognize and destroy cancer cells has afforded …
aim of targeting the immune system to recognize and destroy cancer cells has afforded …
[HTML][HTML] Immuno-oncology: understanding the function and dysfunction of the immune system in cancer
OJ Finn - Annals of oncology, 2012 - Elsevier
The immune system has the greatest potential for the specific destruction of tumours with no
toxicity to normal tissue and for long-term memory that can prevent cancer recurrence. The …
toxicity to normal tissue and for long-term memory that can prevent cancer recurrence. The …
Cytokine-based cancer immunotherapy: Challenges and opportunities for IL-10
KS Rallis, AE Corrigan, H Dadah, AM George… - Anticancer …, 2021 - ar.iiarjournals.org
Cancer immunotherapy is an evolving field of research. Cytokines have been
conceptualized as an anticancer therapy for longer than most other cancer immunotherapy …
conceptualized as an anticancer therapy for longer than most other cancer immunotherapy …
Cancer immunotherapy: harnessing the immune system to battle cancer
Y Yang - The Journal of clinical investigation, 2015 - Am Soc Clin Investig
The recent clinical successes of immune checkpoint blockade and chimeric antigen receptor
T cell therapies represent a turning point in cancer immunotherapy. These successes also …
T cell therapies represent a turning point in cancer immunotherapy. These successes also …
Emerging opportunities and challenges in cancer immunotherapy
TL Whiteside, S Demaria, ME Rodriguez-Ruiz… - Clinical Cancer …, 2016 - AACR
Immunotherapy strategies against cancer are emerging as powerful weapons for treatment
of this disease. The success of checkpoint inhibitors against metastatic melanoma and …
of this disease. The success of checkpoint inhibitors against metastatic melanoma and …
Basic overview of current immunotherapy approaches in cancer
V Velcheti, K Schalper - American Society of Clinical Oncology …, 2016 - ascopubs.org
Recent success of immunotherapy strategies such as immune checkpoint blockade in
several malignancies has established the role of immunotherapy in the treatment of cancer …
several malignancies has established the role of immunotherapy in the treatment of cancer …